scholarly journals Assessment of Dietary Supplementation in the Treatment of Vitiligo

2017 ◽  
Vol 11 (1) ◽  
pp. 12-21
Author(s):  
Mallory K. Smith ◽  
Tasneem F. Mohammad ◽  
Iltefat H. Hamzavi
Keyword(s):  
Recent Literature ◽  
Treatment Options ◽  
Antioxidant Vitamin ◽  
Gluten Free ◽  
Recent Interest ◽  
Therapeutic Value ◽  
Diet Supplement ◽  
Pubmed Search ◽  
The Relationship ◽  
Dietary Modifications

Background: Vitiligo is the most common acquired pigmentary disorder in the world. Due to alterations in physical appearance, vitiligo is a psychologically devastating disease. Although treatment options exist, a cure for this disease has yet to be discovered. Of recent interest in vitiligo is the relationship between diet and disease. Objective: To review various dietary modifications and supplementation used in the management of vitiligo. Materials and Methods: A thorough evaluation of recent literature using the keywords “vitiligo, diet, supplement, antioxidant, vitamin, mineral, zinc, copper, gluten-free, celiac disease, alternative medicine” in the NCBI PubMed search function was performed. Results: A total of 39 relevant articles were reviewed and critically evaluated. Conclusion: Initial studies regarding the treatment of vitiligo through dietary modification are promising, although further studies are needed in multiple populations to explore the therapeutic value of these interventions.

Establishing a Group Educational Session for Hyperacusis Patients

2019 ◽  
Vol 28 (2) ◽  
pp. 245-250
Author(s):  
Ann E. Perreau ◽  
Richard S. Tyler ◽  
Patricia C. Mancini ◽  
Shelley Witt ◽  
Mohamed Salah Elgandy
Keyword(s):  
Therapeutic Process ◽  
Treatment Options ◽  
Clinical Group ◽  
Education Session ◽  
Group Approach ◽  
Treatment Protocols ◽  
Educational Session ◽  
Evidence Based Treatment ◽  
Relationship Of ◽  
The Relationship

Purpose Audiologists should be treating hyperacusis patients. However, it can be difficult to know where to begin because treatment protocols and evidence-based treatment studies are lacking. A good place to start in any tinnitus and hyperacusis clinic is to incorporate a group educational session. Method Here, we outline our approach to establishing a hyperacusis group educational session that includes specific aspects of getting to know each patient to best meet their needs, understanding the problems associated with hyperacusis, explaining the auditory system and the relationship of hyperacusis to hearing loss and tinnitus, describing the influence of hyperacusis on daily life, and introducing treatment options. Subjective responses from 11 adults with hyperacusis, who participated in a recent clinical group education session, were discussed to illustrate examples from actual patients. Conclusions Due to the devastating nature of hyperacusis, patients need to be reassured that they are not alone and that they can rely on audiologists to provide support and guidance. A group approach can facilitate the therapeutic process by connecting patients with others who are also affected by hyperacusis, and by educating patients and significant others on hyperacusis and its treatment options. Supplemental Material https://doi.org/10.23641/asha.8121197

The Non-Causal Character of Renormalization Group Explanations

2018 ◽  
Author(s):  
Margaret Morrison
Keyword(s):  
Probability Theory ◽  
Renormalization Group ◽  
Dynamical Systems ◽  
Recent Literature ◽  
Mathematical Explanation ◽  
Causal Status ◽  
Physical Information ◽  
The Relationship ◽  
Structural Aspects

After reviewing some of the recent literature on non-causal and mathematical explanation, this chapter develops an argument as to why renormalization group (RG) methods should be seen as providing non-causal, yet physical, information about certain kinds of systems/phenomena. The argument centres on the structural character of RG explanations and the relationship between RG and probability theory. These features are crucial for the claim that the non-causal status of RG explanations involves something different from simply ignoring or “averaging over” microphysical details—the kind of explanations common to statistical mechanics. The chapter concludes with a discussion of the role of RG in treating dynamical systems and how that role exemplifies the structural aspects of RG explanations which in turn exemplifies the non-causal features.

Patient-Physician Concordance for Quantitative Formats and Treatment Options and the Relationship with State Anxiety

2021 ◽  
Author(s):  
Alicia J. Smallwood ◽  
Joan M. Neuner ◽  
Kathlyn E. Fletcher ◽  
Cindy M. Walker ◽  
Marilyn M. Schapira
Keyword(s):  
State Anxiety ◽  
Treatment Options ◽  
The Relationship

scholarly journals Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature

2021 ◽  
Vol 49 (10) ◽  
pp. 030006052110532
Author(s):  
Zhe Feng ◽  
Ting Wang ◽  
Sheng Dong ◽  
Hongli Jiang ◽  
Jianzhong Zhang ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Communicable Disease ◽  
Treatment Options ◽  
Narrative Review ◽  
Gut Dysbiosis ◽  
Significant Burden ◽  
Intestinal Ecology ◽  
The Relationship ◽  
Non Communicable Disease

Chronic kidney disease (CKD) is a serious non-communicable disease that poses a significant burden on healthcare and society. It is essential to devise new strategies to better treat patients with CKD. Research has illustrated that gut dysbiosis, describing an abnormal intestinal ecology, is closely associated with CKD. In this narrative review, we summarized the evidence of their mutual relationship and discussed the potential treatment options to correct gut dysbiosis in patients with CKD. Gut dysbiosis significantly increases the risk of CKD, especially in the older population. Gut dysbiosis also plays a role in CKD complications, such as hypertension, cardiovascular events, and cognitive dysfunction. The relationship between gut dysbiosis and CKD is bidirectional, and CKD itself can lead to changes in gut microecology. The usual therapies for CKD can also increase the incidence of gut dysbiosis. Meanwhile, probiotics and antibiotics are generally used to correct gut dysbiosis. Further studies are required to elaborate the association between gut dysbiosis and CKD, and more treatment options should be explored to prevent CKD in patients with gut dysbiosis.

scholarly journals Hyaluronic acid preparations in the treatment of osteoarthritis: is it clear to us?

2018 ◽  
Vol 12 (3) ◽  
pp. 40-52 ◽  
Author(s):  
A. E. Karateev ◽  
Е. Yu. Pogozheva ◽  
V. N. Amirdzhanova ◽  
Е. S. Filatova
Keyword(s):  
Hyaluronic Acid ◽  
Clinical Practice ◽  
Treatment Options ◽  
Social Activity ◽  
Joint Disease ◽  
Saline Injection ◽  
Comparative Efficacy ◽  
Joint Function ◽  
Therapeutic Value ◽  
Real Clinical Practice

Osteoarthritis (OA) is a progressive joint disease that causes persistent pain, limited joint function, disability, and loss of social activity. One of the most popular OA treatment options is intra-articular (I/A) hyaluronic acid (HA) injections. This procedure was introduced into clinical practice in the early 1980s and is used universally. To date, there is no consensus on the therapeutic value of HA. Many investigations confirm that HA is effective as not only a symptomatic agent, but also a structure-modifying one. Some works also show that the effect of HA is equal or only slightly superior to that of placebo (I/A saline injection). The review describes the mechanism of action and comparative efficacy of various (lowand high-molecular weight) HA preparations, as well as the safety of their use in real clinical practice.

scholarly journals Working on dreams, from neuroscience to psychotherapy

2021 ◽  
Vol 24 (2) ◽  
Author(s):  
Giorgio Caviglia
Keyword(s):  
Clinical Practice ◽  
Recent Literature ◽  
Clinical Work ◽  
The Self ◽  
Current Clinical Practice ◽  
The Unconscious ◽  
Psychoanalytic Approach ◽  
The Relationship ◽  
Aggressive Drive ◽  
Cultural Openness

Within the current clinical practice, the debate on the use of dream is still very topical. In this article, the author suggests to address this question with a notable scientific and cultural openness that embraces either the psychoanalytic approach (classical, modern and intersubjective), and the neurophysiological assumptions and both clinical research and cognitive hypotheses. The utility of dream - in the clinical work with patients - is supported by the author with extensive bibliographic references and personal clinical insights, drawn from his experience as a psychotherapist. Results: From an analysis of recent literature on this topic, the dream assumes a very different function and position in the clinical practice: from ‘via regia to the unconscious’ of Freudian theories - an expression of repressed infantile wishes of libidinal or aggressive drive nature - it becomes the very fulcrum of the analysis, a fundamental capacity to be developed, a necessary and decisive element for the patient’s transformation. The dream can also be use with the function of thinking and mentalization, of problem solving, of adaptation, as well as an indicator of the relationship with the therapist in the analytic dialogue or of dissociated aspects of the self. Finally, the author proposes a challenging reading of the clinical relevance of dream: through listening to the dream, the clinician can help the patient to stand in the spaces of his own self in a more open and fluid way and therefore to know himself better, to regulate his affects, to think and to integrate oneself.

scholarly journals Pediatric Optic Neuritis: Description of Four Cases and Review of the Literature

Children ◽  
2021 ◽  
Vol 8 (10) ◽  
pp. 855
Author(s):  
Anna Presicci ◽  
Maria Serra ◽  
Mariaclara Achille ◽  
Elvita Caputo ◽  
Lucia Margari
Keyword(s):  
Optic Neuritis ◽  
Recent Literature ◽  
Systemic Disease ◽  
Treatment Options ◽  
Igg Antibodies ◽  
Careful Evaluation ◽  
Demyelinating Disorders ◽  
Infective Etiology

Pediatric optic neuritis (PON) may be a clinically isolated and self-limiting event or may present in the context of underlying neurologic, infective, or systemic disease. PON has a high impact on the quality of life as it may or may not evolve into other acquired demyelinating syndromes (ADSs), such as multiple sclerosis (MS), neuromyelitis optica (NMO), or other syndromes related to the myelin oligodendrocyte glycoprotein IgG antibodies (MOG-IgG). These different PON phenotypes present variable clinical and radiological features, plasma and liquor biomarkers, and prognosis. We describe four pediatric cases presenting clinically with ON, with different etiopathogenetic pictures: one case had a probable infective etiology, while the others were associated with different demyelinating disorders (MS, NMO, syndrome related to MOG-IgG). We discuss the possible evolution of presenting ON in other ADSs, based on recent literature. A careful evaluation of the clinical and investigation findings and the natural course of PON is necessary to define its pathogenic pathway and evolution. Further prolonged follow-up studies are needed to highlight the predictors of PON evolution, its potential sequelae, and the best treatment options.

scholarly journals Hypoxia-inducible factor–1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma

2014 ◽  
Vol 37 (6) ◽  
pp. E8 ◽  
Author(s):  
Matthew Womeldorff ◽  
David Gillespie ◽  
Randy L. Jensen
Keyword(s):  
Cellular Response ◽  
Treatment Options ◽  
Hypoxia Inducible Factor ◽  
Hypoxia Inducible Factor 1 ◽  
Poor Patient ◽  
Growth Development ◽  
The Relationship ◽  
Insight Into ◽  
Upstream Regulators

Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with an exceptionally poor patient outcome despite aggressive therapy including surgery, radiation, and chemotherapy. This aggressive phenotype may be associated with intratumoral hypoxia, which probably plays a key role in GBM tumor growth, development, and angiogenesis. A key regulator of cellular response to hypoxia is the protein hypoxia-inducible factor–1 (HIF-1). An examination of upstream hypoxic and nonhypoxic regulation of HIF-1 as well as a review of the downstream HIF-1–regulated proteins may provide further insight into the role of this transcription factor in GBM pathophysiology. Recent insights into upstream regulators that intimately interact with HIF-1 could provide potential therapeutic targets for treatment of this tumor. The same is potentially true for HIF-1–mediated pathways of glycolysis-, angiogenesis-, and invasion-promoting proteins. Thus, an understanding of the relationship between HIF-1, its upstream protein regulators, and its downstream transcribed genes in GBM pathogenesis could provide future treatment options for the care of patients with these tumors.

Sa1268 The Relationship Between Self-Reported Strict Adherence to a Gluten-Free Diet and the Ability to Identify Gluten-Containing Foods

2013 ◽  
Vol 144 (5) ◽  
pp. S-247
Author(s):  
Jocelyn A. Silvester ◽  
Dayna Weiten ◽  
Lesley A. Graff ◽  
John R. Walker ◽  
Donald R. Duerksen
Keyword(s):  
Gluten Free Diet ◽  
Gluten Free ◽  
Strict Adherence ◽  
The Relationship

Systemic Monotherapy Treatments for Generalized Pustular Psoriasis: A Systematic Review

2018 ◽  
Vol 22 (6) ◽  
pp. 591-601 ◽  
Author(s):  
Linghong Linda Zhou ◽  
Jorge R. Georgakopoulos ◽  
Arvin Ighani ◽  
Jensen Yeung
Keyword(s):  
Treatment Options ◽  
Treatment Algorithm ◽  
Pustular Psoriasis ◽  
Treatment Modalities ◽  
High Morbidity ◽  
Eligibility Criteria ◽  
Level Of Evidence ◽  
Treatment Regimens ◽  
Generalized Pustular Psoriasis ◽  
Pubmed Search

Generalized pustular psoriasis (GPP) is a rare but serious and difficult to treat cutaneous disease, with high morbidity and mortality rates. Despite the numerous treatment regimens available, the overall quality of evidence-based research is limited with a lack of an algorithmic approach available. In this review, we aim to evaluate the current level of evidence regarding the efficacy and safety/tolerability of systemic monotherapies available in the treatment of GPP. A comprehensive MEDLINE, EMBASE, and PubMed search of clinical studies examining systemic monotherapy treatment options for GPP was conducted. In total, 31 studies met eligibility criteria. Described treatment modalities included retinoids, cyclosporine, biologics, and dapsone. Despite the lack of high-quality evidence or a well-accepted treatment algorithm for GPP, systemic retinoids, cyclosporine, biologics, and dapsone are all possible first-line agents, with retinoids being one of the best-supported treatment options and biologics as an emerging therapeutic field with great potential requiring additional data. However, the final choice of treatment should be considered within the unique context of each patient.

Sign in / Sign up

Export Citation Format

Share Document